FAIRFAX, Calif., Jan 31 /PRNewswire/ -- According to the U.S. Centers for Disease Control and Prevention, there are over six million Americans with diabetes who take insulin. The February 2006 issue of Diabetes Health magazine takes an in-depth look at the shrinking insulin marketplace, and how it affects this patient population.

All people with type 1 diabetes -- and many with type 2 diabetes -- need to take insulin to stay alive. However, over the years, the leading manufacturers of insulin have phased out effective and less-expensive insulins to make way for the newer, more-expensive ones. Recently, 66,000 insulin-using diabetics lost their long-acting insulin option when Ultralente and Lente were removed from the insulin market. The only thing that remains as a long-acting insulin option is the popular-and pricey-Lantus insulin.

But, is Lantus really all that safe? Is it possible that it has long-term cancer potential? In an investigative study, Diabetes Health magazine reveals that it just might.

To read this groundbreaking article in its entirety, visit http://www.diabeteshealth.com/insulin .

For more in-depth information about Diabetes Health magazine and living well with diabetes, contact Daniel Trecroci at 800-234-1218 x 108 or via email by visiting our online form at http://www.diabeteshealth.com/contact .

Diabetes Health has provided coverage of inspirational, poignant issues such as this one since 1991. It is the third largest U.S. consumer magazine dedicated to diabetes. Anyone can request a free trial issue by visiting http://www.diabeteshealth.com/prsubs or calling 1-800-488-8468.

CONTACT: Daniel Trecroci of Diabetes Health, +1-415-258-2828, ext. 108,
or daniel@diabeteshealth.com

Web site: http://www.diabeteshealth.com/